Bayer AG buys BlueRock Therapeutics for $1 bln
Bayer AG has acquired BlueRock Therapeutics from Versant Ventures for up to $1 billion. BlueRock, a biotech, focuses on stem cell research.
8 August 2019•4 mins read
Bayer AG has acquired BlueRock Therapeutics from Versant Ventures for up to $1 billion. BlueRock, a biotech, focuses on stem cell research.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
3 hours ago · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
9 hours ago · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
9 hours ago · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
9 hours ago · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
11 hours ago · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
12 hours ago · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
